## Background: Epidermal growth factor (egf) and its receptor (egfr) are involved in the development of salivary gland tumors. recently, treatment modalities for egfr inhibition have shown an enhanced clinical response in carcinomas of different locations. adenoid cystic carcinoma (acc) of salivary
Immunohistochemical study of epidermal growth factor and epidermal growth factor receptor in gastric carcinoma
β Scribed by Kazuo Sugiyama; Yutaka Yonemura; Itsuo Miyazaki
- Publisher
- John Wiley and Sons
- Year
- 1989
- Tongue
- English
- Weight
- 503 KB
- Volume
- 63
- Category
- Article
- ISSN
- 0008-543X
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
malignancies including carcinoma of the breast, lung, esophagus, cervix, and stomach. In patients with gastric carcinoma, its overexpression may be associated with
## Abstract Recent studies have indicated that somatic mutations in the epidermal growth factor receptor (EGFR) gene have been identified in a subset of patients with nonsmallβcell lung cancer (NSCLC) and are associated with sensitivity to the EGFRβtyrosineβkinase inhibitors. These mutations have b
Cell motility is induced by many growth factors acting through cognate receptors with intrinsic tyrosine kinase activity (RPTK). However, most of the links between receptor activation and the biophysical processes of cell motility remain undeciphered. We have focused on the mechanisms by which the E